Cas no 103986-07-8 (2,3-Dimethyl-1H-indole-7-carboxylic acid)
2,3-Dimethyl-1H-indole-7-carboxylic acid Chemical and Physical Properties
Names and Identifiers
-
- 2,3-Dimethyl-1H-indole-7-carboxylic acid
- 2,3-dimethyl-1H-indole-7-carboxylic acid(SALTDATA: FREE)
- 2,3-dimethyl-1H-indole-7-carboxylic acid(SALTDATA
- Z316119556
- MFCD00090259
- ALBB-007740
- CHEMBL5184170
- F2113-0263
- 103986-07-8
- 2,3-DIMETHYL-7-INDOLECARBOXYLIC ACID
- ITMIUTVFOTYMOJ-UHFFFAOYSA-N
- E76055
- EN300-30851
- AKOS000142311
- 2,3-Dimethyl-1H-indole-7-carboxylicacid
- DTXSID90395255
- LS-02873
- STK504757
- 2,3-dimethylindole-7-carboxylic acid
- SCHEMBL6691799
-
- MDL: MFCD00090259
- Inchi: 1S/C11H11NO2/c1-6-7(2)12-10-8(6)4-3-5-9(10)11(13)14/h3-5,12H,1-2H3,(H,13,14)
- InChI Key: ITMIUTVFOTYMOJ-UHFFFAOYSA-N
- SMILES: OC(C1=CC=CC2C(C)=C(C)NC=21)=O
Computed Properties
- Exact Mass: 189.079
- Monoisotopic Mass: 189.079
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 2
- Hydrogen Bond Acceptor Count: 3
- Heavy Atom Count: 14
- Rotatable Bond Count: 1
- Complexity: 241
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 2.3
- Topological Polar Surface Area: 53.1?2
Experimental Properties
- PSA: 53.09000
- LogP: 2.48290
2,3-Dimethyl-1H-indole-7-carboxylic acid Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | 038867-500mg |
2,3-Dimethyl-1H-indole-7-carboxylic acid |
103986-07-8 | 500mg |
4096.0CNY | 2021-07-05 | ||
| SHANG HAI JI ZHI SHENG HUA Technology Co., Ltd. | X51375-1g |
2,3-Dimethyl-1H-indole-7-carboxylic acid |
103986-07-8 | 95% | 1g |
¥1132.0 | 2023-09-05 | |
| SHANG HAI JI ZHI SHENG HUA Technology Co., Ltd. | X51375-250mg |
2,3-Dimethyl-1H-indole-7-carboxylic acid |
103986-07-8 | 95% | 250mg |
¥453.0 | 2023-09-05 | |
| SHANG HAI JI ZHI SHENG HUA Technology Co., Ltd. | X51375-100mg |
2,3-Dimethyl-1H-indole-7-carboxylic acid |
103986-07-8 | 95% | 100mg |
¥303.0 | 2023-09-05 | |
| Chemenu | CM240409-1g |
2,3-Dimethyl-1H-indole-7-carboxylic acid |
103986-07-8 | 95% | 1g |
$281 | 2021-08-04 | |
| TRC | D474960-25mg |
2,3-Dimethyl-1H-indole-7-carboxylic Acid |
103986-07-8 | 25mg |
$ 50.00 | 2022-06-05 | ||
| TRC | D474960-50mg |
2,3-Dimethyl-1H-indole-7-carboxylic Acid |
103986-07-8 | 50mg |
$ 65.00 | 2022-06-05 | ||
| TRC | D474960-250mg |
2,3-Dimethyl-1H-indole-7-carboxylic Acid |
103986-07-8 | 250mg |
$ 210.00 | 2022-06-05 | ||
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | B-DE858-50mg |
2,3-Dimethyl-1H-indole-7-carboxylic acid |
103986-07-8 | 95+% | 50mg |
172.0CNY | 2021-07-13 | |
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | B-DE858-200mg |
2,3-Dimethyl-1H-indole-7-carboxylic acid |
103986-07-8 | 95+% | 200mg |
415.0CNY | 2021-07-13 |
2,3-Dimethyl-1H-indole-7-carboxylic acid Related Literature
-
Huiying Xu,Lu Zheng,Yu Zhou,Bang-Ce Ye Analyst, 2021,146, 5542-5549
-
Hamid Heydari,Mohammad B. Gholivand New J. Chem., 2017,41, 237-244
-
Yang Xu,Min Wang,Donghui Wei,Rongqiang Tian,Zheng Duan,Fran?ois Mathey Dalton Trans., 2019,48, 5523-5526
-
Bidou Wang,Xifeng Chen Analyst, 2014,139, 5695-5699
Additional information on 2,3-Dimethyl-1H-indole-7-carboxylic acid
Introduction to 2,3-Dimethyl-1H-indole-7-carboxylic acid (CAS No. 103986-07-8)
2,3-Dimethyl-1H-indole-7-carboxylic acid, identified by the Chemical Abstracts Service Number (CAS No.) 103986-07-8, is a significant compound in the field of organic chemistry and pharmaceutical research. This heterocyclic aromatic acid derivative has garnered attention due to its structural uniqueness and potential biological activities. The presence of two methyl groups at the 2- and 3-positions of the indole ring, coupled with a carboxylic acid functional group at the 7-position, imparts distinct chemical and pharmacological properties that make it a valuable scaffold for drug discovery and material science applications.
The molecular structure of 2,3-Dimethyl-1H-indole-7-carboxylic acid consists of a benzene-like core with an indole moiety, which is a fused system of a benzene ring and a pyrrole ring. This structural motif is commonly found in numerous bioactive natural products and pharmaceuticals, suggesting that derivatives of this compound may exhibit promising biological functions. The carboxylic acid group not only influences the solubility and reactivity of the molecule but also serves as a key site for further functionalization, enabling the synthesis of more complex derivatives.
In recent years, there has been growing interest in indole derivatives due to their diverse biological activities. Studies have demonstrated that indole-based compounds can modulate various cellular processes, including enzyme inhibition, receptor binding, and antioxidant effects. Among these derivatives, 2,3-Dimethyl-1H-indole-7-carboxylic acid has shown particular promise in preclinical studies as a potential therapeutic agent. Its ability to interact with biological targets such as enzymes and receptors makes it an attractive candidate for further investigation in medicinal chemistry.
One of the most compelling aspects of 2,3-Dimethyl-1H-indole-7-carboxylic acid is its versatility in chemical synthesis. The compound can be used as a building block for more complex molecules through various synthetic pathways, including esterification, amidation, and alkylation. These modifications allow researchers to fine-tune the pharmacological properties of the derivative, making it possible to develop novel drugs with enhanced efficacy and reduced side effects. The carboxylic acid group at the 7-position provides a convenient handle for these transformations, facilitating the creation of diverse chemical libraries for high-throughput screening.
Recent advancements in computational chemistry have also contributed to the study of 2,3-Dimethyl-1H-indole-7-carboxylic acid. Molecular modeling techniques have been employed to predict the binding affinity of this compound to various biological targets, providing insights into its potential mechanisms of action. These computational studies have helped guide experimental efforts, allowing researchers to prioritize which derivatives are most likely to exhibit desirable biological activities. Additionally, virtual screening methods have been used to identify new synthetic routes for this compound, further expediting its development as a pharmacological tool.
The pharmacological potential of 2,3-Dimethyl-1H-indole-7-carboxylic acid has been explored in several contexts. In particular, its derivatives have shown promise as inhibitors of enzymes involved in inflammatory pathways. By modulating these enzymes, indole-based compounds may offer therapeutic benefits in conditions such as arthritis and autoimmune diseases. Furthermore, studies have suggested that derivatives of this compound may possess antioxidant properties, making them useful in combating oxidative stress-related disorders such as neurodegenerative diseases.
Another area where 2,3-Dimethyl-1H-indole-7-carboxylic acid has found utility is in the field of material science. Its aromatic structure and functional groups make it a suitable candidate for designing organic semiconductors and liquid crystals. These materials are used in various applications, including electronic displays and optical devices. The ability to tailor the properties of these materials by modifying the structure of 2,3-Dimethyl-1H-indole-7-carboxylic acid opens up new possibilities for innovation in this sector.
The synthesis of 2,3-Dimethyl-1H-indole-7-carboxylic acid can be achieved through several routes depending on the starting materials and desired purity. One common method involves the cyclization of appropriately substituted indoles followed by oxidation to introduce the carboxylic acid group. Alternatively, palladium-catalyzed cross-coupling reactions can be employed to construct the indole core from simpler precursors. These synthetic strategies have been optimized over time to improve yield and efficiency, making it feasible to produce this compound on both laboratory and industrial scales.
In conclusion,2,3-Dimethyl-1H-indole-7-carboxylic acid (CAS No. 103986-07-8) is a versatile and promising compound with significant applications in pharmaceuticals and material science. Its unique structural features and potential biological activities make it an attractive scaffold for drug discovery efforts aimed at developing novel therapeutics for various diseases. Furthermore,its utility in designing advanced materials underscores its importance beyond traditional medicinal chemistry applications。 As research continues,the full potential of this compound is expected to be further uncovered,leading to innovative solutions across multiple scientific disciplines。
103986-07-8 (2,3-Dimethyl-1H-indole-7-carboxylic acid) Related Products
- 9327-78-0(Methylindole-7-carboxylate)
- 73126-42-8(2-formyl-1H-indole-3-carboxylic acid)
- 889943-11-7(1H-Indole-3-carboxylicacid, 2,5-dimethyl-)
- 103986-06-7(2,3-Dimethyl-1H-indole-6-carboxylic Acid)
- 104785-55-9(2,4-Dimethylquinoline-3-carboxylic acid)
- 14844-73-6(2,3-Dimethyl-1H-indole-5-carboxylic acid)
- 63176-44-3(2-Methyl-1H-indole-3-carboxylic acid)
- 88344-65-4(2-Methylquinoline-3,4-dicarboxylic acid)
- 92513-34-3(2,7,8-Trimethylquinoline-3-carboxylic Acid)
- 1227267-27-7(2,6-Dimethyl-1H-indole-3-carboxylic acid)